NCT01337986 - Ampyra for Optic Neuritis in Multiple Sclerosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions

Multiple SclerosisOptic Neuritis

Interventions

DRUG

Dalfampridine/Placebo

Weeks 1-3: Dalfampridine 10mg (1 tablet) every 12 hours for 3 weeks. Weeks 4-5: 2 weeks of wash-out. Weeks 5-8: Placebo (sugar pill) 1 tablet every 12 hours for 3 weeks.

DRUG

Placebo/Dalfampridine

Weeks 1-3: Placebo (sugar pill) 1 tablet every 12 hours for 3 weeks. Weeks 4-5: 2 weeks of wash-out. Weeks 6-8: Dalfampridine 10mg (1 tablet) every 12 hours for 3 weeks.

Trial Locations (1)

63110

Washington University (John L. Trotter MS Center), St Louis